CD8A and myeloid sarcoma: Aged MS patients who are in advanced phase of the disease do not have enough CD8+ T cells in their circulation and consequently in their lung tissue to fight against viral antigens and increased infectious risk [98] exacerbating the neurological signs of the patients [103–106].